Jeffrey Lawrence Schwartz
CIK 1702957 · Chief Executive Officer · last filed 2025-09-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$612.60M
Companies
7
Total Filings
17
Lifetime Open-Market Net
-$294.42M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KMTS | Director | 27,030,134 | $20.85 | $563.58M | $0 | 1 | 2025-09-08 |
| RPID | Director | 8,448,860 | $1.76 | $14.87M | $0 | 4 | 2024-05-28 |
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Director | 3,091,879 | $46.99 | $145.29M | -$320.07M | 8 | 2023-05-25 |
| BCLS Acquisition Corp. (BLSA) Delisted | Chief Executive Officer | 487,500 | $10.04 | $4.89M | $0 | 1 | 2020-10-26 |
| ANNX | 10%+ Owner | 2,841,628 | $4.71 | $13.38M | $40.80M | 1 | 2020-07-28 |
| REPL | 10%+ Owner | 2,338,968 | $8.88 | $20.77M | $45.00M | 1 | 2018-07-26 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | 10%+ Owner | 3,977,453 | $0.55 | $2.19M | -$60.15M | 1 | 2017-12-19 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-10-26 | BCLS Acquisition Corp. (BLSA) Delisted | Grant (A) | +487,500 | $4.88M | EDGAR |
| 2020-07-28 | ANNX | Mixed | +19,449,768 | $40.80M | EDGAR |
| 2020-05-22 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-19 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Mixed | +29,125,228 | $10.80M | EDGAR |
| 2019-09-16 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-26 | REPL | Mixed | +17,033,808 | $45.00M | EDGAR |
| 2017-12-19 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Sell (S) | −7,635,282 | -$60.15M | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.